| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 03/04/2004 | WO2003012034A9 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/04/2004 | WO2002103052B1 Amplifiable probe |
| 03/04/2004 | WO2001073123B1 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/04/2004 | US20040044219 Probe for analysis of nucleic acids |
| 03/04/2004 | US20040044195 Process for separating and deprotecting oligonucleotides |
| 03/04/2004 | US20040044190 Purification of oligomers |
| 03/04/2004 | US20040044182 Genetically engineered human leukocyte antigen-g polypeptide (HLA-G) for altering immunological response during organ transplantation and gestations involving genetically different fetuses |
| 03/04/2004 | US20040044181 Novel nucleic acids and polypeptides |
| 03/04/2004 | US20040044179 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 03/04/2004 | US20040043951 Hydrogelation agents |
| 03/04/2004 | US20040043941 Antiinflamamtory agents; autoimmune disease; anticancer agents |
| 03/04/2004 | US20040043930 Novel proteins and nucleic acids encoding same |
| 03/04/2004 | US20040043927 Wound healing agents; anticancer agents; cardiovascular disorders |
| 03/04/2004 | US20040043923 Detection, calibration binding of ligand to nucleic acids |
| 03/04/2004 | US20040043454 Growth arrest homeobox gene |
| 03/04/2004 | US20040043452 Comprises embryogenesis associated proteins (EMBRY) for diagnosis, treatment and prevention of reproductive, autoimmune/inflammatory and placental disorders |
| 03/04/2004 | US20040043450 Bioactive peptide for cell adhesion |
| 03/04/2004 | US20040043447 Production of sulfated polysaccharides using glycosaminoglycan-specific sulfotransferases |
| 03/04/2004 | US20040043424 Immunoglobulin superfamily proteins |
| 03/04/2004 | US20040043415 Comprises nucleotide sequences coding heat resistant synthetase for use as replication tool in genetic engineering and molecular cloning |
| 03/04/2004 | US20040043414 Nucleic acid encoding bacillus stearothermophilus tau polymerase subunit |
| 03/04/2004 | US20040043404 A chemical moiety that prohibits recrystallization of a denatured DNAportion |
| 03/04/2004 | US20040043401 Nucleic acids encoding chimeric T cell receptors (TCRs), methods of using them to facilitate a T cell response to a selected target |
| 03/04/2004 | US20040043397 Identification and isolation of novel DNA and the recombinant production of polypeptides having sequence similarity to interleukin-17 and interleukin-17 receptor protein |
| 03/04/2004 | US20040043394 Arylhydrocarbon receptor (AhR) |
| 03/04/2004 | US20040043387 Nucleic acid molecules and polypeptides related to h-ADAM7 |
| 03/04/2004 | US20040043383 Method and probes for the detection of chromosome aberrations |
| 03/04/2004 | DE10238978A1 Method for preparing ketocarotenoids, useful e.g. as food or feed supplements, by increasing, or introducing, ketolase activity in the fruits of transgenic plants, also new nucleic acid constructs |
| 03/04/2004 | DE10141464A1 New nucleic acid representing a polymorphism in the 22444 gene, useful for diagnosis and treatment of neuropsychiatric diseases and in drug screening |
| 03/04/2004 | CA2496732A1 Synthetic heparin-binding growth factor analogs |
| 03/04/2004 | CA2496207A1 Method for the production of zeaxanthin and/or the biosynthetic intermediates and/or subsequent products thereof |
| 03/04/2004 | CA2496133A1 Method for the production of ketocarotinoids in flower petals on plants |
| 03/04/2004 | CA2495878A1 Method for producing ketocarotinoids in genetically modified organisms |
| 03/04/2004 | CA2495444A1 Method for producing ketocarotinoids in plant fruit |
| 03/04/2004 | CA2495235A1 Use of astaxanthin-containing plants or parts of plants of the genus tagetes as animal feed |
| 03/04/2004 | CA2494993A1 Abasic site endonuclease assay |
| 03/04/2004 | CA2494806A1 Expression vectors encoding epitopes of target-associated antigens |
| 03/03/2004 | EP1394259A2 Recombinant infectious non-segmented negative strand RNA virus |
| 03/03/2004 | EP1394255A2 NANBV diagnostics and vaccines |
| 03/03/2004 | EP1394173A1 Improved method for bisulfite treatment |
| 03/03/2004 | EP1394172A1 Improved method for bisulfite treatment |
| 03/03/2004 | EP1393745A1 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5'ends |
| 03/03/2004 | EP1392872A2 Non-alloying core shell nanoparticles |
| 03/03/2004 | EP1392868A1 Method for the synthesis of dna sequences |
| 03/03/2004 | EP1392862A2 Nucleic acids of the human abca12 gene, vectors containing such nucleic acids, and uses thereof |
| 03/03/2004 | EP1392820A1 Cyp450-specific dna probes and primers, and biological applications thereof |
| 03/03/2004 | EP1392717A1 Rapidly cleavable sumo fusion protein expression system for difficult to express proteins |
| 03/03/2004 | EP1062224A4 Modified factor viii |
| 03/03/2004 | EP0983290B1 Method for producing polymers having nucleo-bases as side-groups |
| 03/03/2004 | EP0948518B1 Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof |
| 03/03/2004 | EP0831850B1 Use of locally applied dna fragments |
| 03/03/2004 | CN1479745A Process for preparation of thiophosphate oligonucleotides |
| 03/03/2004 | CN1478897A Plant polygene expression carrier, transforming factor containing said carrier and its application |
| 03/03/2004 | CN1478789A Preparation method of ribonucleic acid |
| 03/03/2004 | CN1478788A Primer, probe and fast detecting method for detecting wheat India bunt bacteria and rye smut |
| 03/02/2004 | US6699987 Isolation nucleic acids by binding to solid phase |
| 03/02/2004 | US6699986 Preferably at a ph of about 2 to about 4. |
| 03/02/2004 | US6699979 Oligonucleotides having chiral phosphorus linkages |
| 03/02/2004 | US6699978 Linker nucleoside, and production and use of the same |
| 03/02/2004 | US6699975 Fluorescent quenching detection reagents and methods |
| 03/02/2004 | US6699843 Method for treatment of tumors using nucleic acid ligands to PDGF |
| 03/02/2004 | US6699703 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 03/02/2004 | US6699690 Linked and controlling the expression of a heterologous enzyme, for example varicella zoster virus thymidine kinase or non-mammaliam cytosine deaminase |
| 03/02/2004 | US6699688 Human platelet F11 receptor |
| 03/02/2004 | US6699668 For determining hybridization by cleaving the label from the hybridized probe, where each mass label is relatable to the probe's base sequence by mass spectrometry |
| 03/02/2004 | US6699660 Isolated nucleic acid identical to one expressed in response to seizure or ischemia |
| 02/26/2004 | WO2004017062A1 The method and device for accelerating molecular hybridization by ultrasonic wave |
| 02/26/2004 | WO2004016805A2 Immunostimulatory nucleic acids |
| 02/26/2004 | WO2004016760A2 Novel variant hyprocrea jecorina cbh1 cellulases |
| 02/26/2004 | WO2004016757A2 Methods, compositions and kits for producing nucleic and acid sequences |
| 02/26/2004 | WO2004016755A2 Amplification of target nucleotide sequence without polymerase chain reaction |
| 02/26/2004 | WO2004016748A2 Biotinylation of proteins |
| 02/26/2004 | WO2004016732A2 Astrocyte modulated genes and uses thereof |
| 02/26/2004 | WO2004016639A1 Bmp-2 estrogen responsive element and methods of using the same |
| 02/26/2004 | WO2004016638A1 Aptamer-mediated regulation of gene expression |
| 02/26/2004 | WO2004016637A1 Gene families associated with liver cancer |
| 02/26/2004 | WO2004016636A1 Gene families associated with stomach cancer |
| 02/26/2004 | WO2004016349A2 Method and device for the intermolecular transport of bond cleavage activation energy through space |
| 02/26/2004 | WO2004016215A2 Use of antisense oligonucleotides to inhibit the expression of akt-1 |
| 02/26/2004 | WO2004016154A2 Molecular lymphatic mapping of sentinel lymph nodes |
| 02/26/2004 | WO2004001033A3 A method of cleaving labile functional groups from chemical compounds |
| 02/26/2004 | WO2003099204A3 Antisense modulation of inhibitor-kappa b kinase-beta expression |
| 02/26/2004 | WO2003097688A3 Muteins of placental growth factor type 1, preparation method and application thereof |
| 02/26/2004 | WO2003091311A8 Monomers containing polyoxyalkylenes and polymer supports therefrom |
| 02/26/2004 | WO2003068911A3 Citrus tristeza virus resistance genes and methods of use |
| 02/26/2004 | WO2003066812A3 Substituted 4,4-difluoro-4-bora-3a, 4a-diaza-s-indacene compounds for 8-color dna sequencing |
| 02/26/2004 | WO2003064615A3 Amplifying repetitive nucleic acid sequences |
| 02/26/2004 | WO2003060071A3 Albumin fusion proteins |
| 02/26/2004 | WO2003057822A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 02/26/2004 | WO2003046146A3 Compositions and methods of selective nucleic acid isolation |
| 02/26/2004 | WO2003039476A3 Methods and compositions for treating hematological disorders using 232, 2059, 10630, 12848, 13875, 14395, 14618, 17692 or 58874 |
| 02/26/2004 | WO2002083917A8 Nucleic acid and corresponding protein entitled 161p5c5 useful in treatment and detection of cancer |
| 02/26/2004 | WO2002036831A3 Canola event pv-bngt04(rt73) and compositions and methods for detection thereof |
| 02/26/2004 | US20040039532 Feature quality in array fabrication |
| 02/26/2004 | US20040039189 Solid phase synthesis; linkers allow for regeneration of surfaces without damage |
| 02/26/2004 | US20040039187 Chimeric GB virus B (GBV-B) |
| 02/26/2004 | US20040039164 Invention relates to identification and isolation of novel DNA and to recombinant production of novel polypeptides |
| 02/26/2004 | US20040039116 A solid support comprising a diol group for bonding to oligonucleotides, proteins, cells, and coupling to substrate with a silane compound |
| 02/26/2004 | US20040038925 Inhibition of complement activation and complement modulation by use of modified oligonucleotides |
| 02/26/2004 | US20040038881 For diagnosis, therapy and prophylaxis of cancer, immune disorders, disorders affecting growth and development, cardiovascular diseases, and lipid disorders |